Performance parameters of the diagnostic scoring systems for autoimmune hepatitis

Hepatology

Volumn 48, Issue 5, 2008, Pages 1540-1548

  Czaja, Albert J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOPATHOLOGY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; CHRONIC DISEASE; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LIVER DISEASE; LIVER FUNCTION TEST; PATHOLOGY;

AUTOANTIBODY; HEPATITIS B SURFACE ANTIGEN; HLA ANTIGEN; IMMUNOGLOBULIN G;

AUTOANTIBODIES; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS, AUTOIMMUNE; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; LIVER DISEASES; LIVER FUNCTION TESTS; MALE;

EID: 56149102474     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22513     Document Type: Article

References (36)

1. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Bianchi L, Burroughs A, et al. Meeting report. International Autoimmune Hepatitis Group. HEPATOLOGY 1993;18:998-1005.
2. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.
3. Czaja AJ, Carpenter HA. Validation of a scoring system for the diagnosis of autoimmune hepatitis. Dig Dis Sci 1996;41:305-314.
4. Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. HEPATOLOGY 1996;23:1369-1376.
5. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified diagnostic criteria for autoimmune hepatitis. HEPATOLOGY 2008;48:169-176.
6. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. HEPATOLOGY 2002;36:479-497.
7. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. HEPATOLOGY 1994;19:1513-1520.
8. Lok AS, McMahon BJ. Chronic hepatitis B. HEPATOLOGY 2007;45:507-539.
9. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122:1649-1657.
10. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single-Topic Conference. HEPATOLOGY 2003;37: 1202-1219.
11. Taal BG, Schalm SW, ten Kate FW, Hermans J, Geertzen RG, Feltkamp BE. Clinical diagnosis of primary biliary cirrhosis: A classification based on major and minor criteria. Hepatogastroenterology 1983;30:178-182.
12. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79:200-206.
13. Czaja AJ. Chronic active hepatitis: The challenge for a new nomenclature. Ann Intern Med 1993;119:510-517.
14. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996;125:588-598.
15. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Homburger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 1993;104:1755-1761.
16. Gassert DJ, Garcia H, Tanaka K, Reinus JF. Corticosteroid-responsive cryptogenic chronic hepatitis: Evidence of seronegative autoimmune hepatitis. Dig Dis Sci 2007;52:2433-2437.
17. Dunn W, Angulo P, Sanderson S, Jamil LH, Stadheim L, Rosen C, et al. Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology 2006;131:1057-1063.
18. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. HEPATOLOGY 1996;24:1068-1073.
19. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci 1997;42:1688-1696.
20. Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992;103:1290-1295.
21. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 1993;105:1522-1528.
22. Montano-Loza AJ, Carpenter HA, Czaja AJ. Frequency, behavior and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J Clin Gastroenterol. In press.
23. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993;105:1824-1832.
24. Czaja AJ, Carpenter HA. Optimizing diagnosis from the medical liver biopsy. Clin Gastroenterol Hepatol 2007;5:898-907.
25. Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WHJ. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 1975;20:1087-1090.
26. Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. HEPATOLOGY 1997;25:317-323.
27. Mytilineos J, Scherer S, Opelz G. Comparison of RFLP-DR beta and serological HLA-DR typing in 1500 individuals. Transplantation 1990; 50:870-873.
28. Terasaki P, McClelland JD, Park MS, McCurdy B. Microdroplet lymphocyte cytotoxicity test. In: DHEW Publication (NIH) 74-545. Manual of tissue typing techniques. Washington, DC: US Government Printing Office, 1973:54-61.
29. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. HEPATOLOGY 1998;28:360-365.
30. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J Hepatol 1996;24:52-59.
31. Loria P, Lonardo A, Leonardi F, Fontana C, Carulli L, Verrone AM, et al. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci 2003;48:2173-2181.
32. Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2004;99:1316-1320.
33. Czaja AJ. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: A foray across diagnostic boundaries. J Hepatol 2006;44:251-252.
34. Talwalkar JA, Keach JC, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: An evaluation of a modified scoring system. Am J Gastroenterol 2002;97:1191-1197.
35. Czaja AJ, Bianchi FB, Carpenter HA, Krawitt EL, Lohse AW, Manns MP, et al. Treatment challenges and investigational opportunities in autoimmune hepatitis. HEPATOLOGY 2005;41:207-215.
36. Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome. HEPATOLOGY 2005;42:53-62.